speb/financial-data huggingface dataset:
Financial ratios for RLF.AX — annual report dated 2022-06-30
Total revenue: 7353793.103448276
Gross profit: 3740689.6551724137
Operating income: -1902758.6206896552
Net income: -2068965.5172413795
Capital expenditures: 24137.93103448276
Depreciation & amortization: 168275.86206896554
Net tangible assets: 4243448.275862069
Owner earnings: -1924827.5862068967
Return on net tangible assets (%): -45.35998699821226
Buffett classification: The Gruesome
Stock price: 0.08275862068965517
Shares outstanding: 537657047
Book value: 8457241.379310343
P/B ratio: 5.261261162847592
Market cap (USD): 44495755.613793105
Debt to equity: 0.06792791323493436
Current ratio: 6.798903107861061
Quick ratio: 5.449725776965265
Interest coverage ratio: -9.320945945945946
COGS to revenue (%): 49.13251430179124
R&D to revenue (%): 1.500515802307043
SG&A to revenue (%): 44.94044827909594
Free cash flow (dilution-adjusted): -1553103.448275862
Buyback yield (%): 1.6816791888280909
Retained earnings: -7086896.551724138
Inventory turnover: 2.366305329719964
Receivables turnover: 12.25632183908046
Capitalized R&D asset: 110344.8275862069
ROCI (R&D-adjusted, %): -15.677582062497535
FCF margin (%): -21.11975991747163
Rule of 40 score: -21.11975991747163
Financial ratios for RLF.AX — annual report dated 2023-06-30
Total revenue: 7513245.033112583
Gross profit: 3974834.437086093
Operating income: -2131788.0794701986
Net income: -2274834.437086093
Capital expenditures: 233774.8344370861
Depreciation & amortization: 162251.65562913907
Net tangible assets: -116556.29139072848
Owner earnings: -2346357.61589404
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 537657047
Book value: 1348344.3708609268
P/B ratio: 34.32977215618861
Market cap (USD): 46288355.03973509
Debt to equity: 1.0471512770137528
Current ratio: 1.9286943223093098
Quick ratio: 1.3131332441215826
Interest coverage ratio: -57.482142857142854
COGS to revenue (%): 47.09563684442485
SG&A to revenue (%): 43.234905244601144
Free cash flow (dilution-adjusted): -2503973.509933775
Buyback yield (%): 0.004292126961915014
Retained earnings: -9080132.450331125
Inventory turnover: 1.6593167701863352
Receivables turnover: 4.514524472741742
Capitalized R&D asset: 73931.03448275862
ROCI (R&D-adjusted, %): -31.688171265108235
Rosenberg metric: 2.121937086092717
FCF margin (%): -33.32745702952843
Revenue growth (%): 2.168295020287388
Rule of 40 score: -31.159162009241044
Financial ratios for RLF.AX — annual report dated 2024-06-30
Total revenue: 6502000
Gross profit: 2788000
Operating income: -4708666.666666667
Net income: -5346666.666666667
Capital expenditures: 196000
Depreciation & amortization: 256000
Net tangible assets: -2524000
Owner earnings: -5286666.666666667
Buffett classification: The Gruesome
Stock price: 0.03333333333333333
Shares outstanding: 537657047
Book value: 2352000
P/B ratio: 7.619856108276644
Market cap (USD): 17921901.566666666
Debt to equity: 1.7434807256235827
Current ratio: 0.8297242429368973
Quick ratio: 0.5389950938927424
Interest coverage ratio: -33.15962441314554
COGS to revenue (%): 57.120885881267306
SG&A to revenue (%): 101.82507946272943
Free cash flow (dilution-adjusted): -49333.333333333336
Buyback yield (%): 0.49473916781007066
Retained earnings: -14353333.333333334
Inventory turnover: 1.6208903113180098
Receivables turnover: 6.5898648648648654
Capitalized R&D asset: 36413.793103448275
ROCI (R&D-adjusted, %): -65.09757051314395
FCF margin (%): -0.7587409002358249
Revenue growth (%): -13.45949757602468
Rule of 40 score: -14.218238476260504
Financial ratios for SBIO.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.220472440944882
Shares outstanding: 22014377
Market cap (USD): 26867940.43307087
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBIO.V — annual report dated 2022-12-31
Total revenue: 42305732
Gross profit: 25350591
Operating income: -234011
Net income: -846765
Capital expenditures: 140130
Operating cash flow: 2086184
Depreciation & amortization: 716532
Net tangible assets: -484876
Owner earnings: -270363
Buffett classification: The Gruesome
Stock price: 0.5882352941176471
Shares outstanding: 22014377
Book value: 2348054
P/B ratio: 5.515049283113491
Market cap (USD): 12949633.529411765
Debt to equity: 2.5741626896144636
Current ratio: 0.9800795802983445
Quick ratio: 0.9800795802983445
Interest coverage ratio: -0.5606907193275861
COGS to revenue (%): 40.07764479763641
R&D to revenue (%): 12.564860005258863
SG&A to revenue (%): 46.21693816809505
Free cash flow (dilution-adjusted): 1188569
Buyback yield (%): 0
Retained earnings: -11054886
Receivables turnover: 3.225127704995229
Capitalized R&D asset: 5315656
ROCI (R&D-adjusted, %): 35.69405735628315
FCF margin (%): 2.809475084841931
Rule of 40 score: 2.809475084841931
Financial ratios for SBIO.V — annual report dated 2023-12-31
Total revenue: 35954934
Gross profit: 21780302
Operating income: -3723841
Net income: -4764536
Capital expenditures: 165746
Operating cash flow: -4972199
Depreciation & amortization: 768160
Net tangible assets: -3910520
Owner earnings: -4162122
Buffett classification: The Gruesome
Stock price: 0.22727272727272727
Shares outstanding: 22014377
Book value: -1080717
Market cap (USD): 5003267.5
Debt to equity: -10.378656021881769
Current ratio: 0.8255594626129249
Quick ratio: 0.8255594626129249
Interest coverage ratio: -3.5494223840478867
COGS to revenue (%): 39.423329215400585
R&D to revenue (%): 13.068701502831296
SG&A to revenue (%): 55.72848499735809
Free cash flow (dilution-adjusted): -5909435
Buyback yield (%): 0
Retained earnings: -15819422
Receivables turnover: 3.094599644742235
Capitalized R&D asset: 8260332.52
ROCI (R&D-adjusted, %): -22.09143403134369
Rosenberg metric: -0.6716553892877944
FCF margin (%): -16.435671944217724
Revenue growth (%): -15.011672649937838
Rule of 40 score: -31.44734459415556
Financial ratios for SBIO.V — quarterly report dated 2024-09-30
Operating income: 2093321
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.37037037037037035
Shares outstanding: 22014377
Market cap (USD): 8153472.962962963
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBIO.V — annual report dated 2024-12-31
Total revenue: 49602885
Gross profit: 30627389
Operating income: 2065818
Net income: -110875
Capital expenditures: 102861
Operating cash flow: 3773029
Depreciation & amortization: 882923
Net tangible assets: -3710643
Owner earnings: 669187
Capex to operating income (%): 4.979189841505883
Buffett classification: The Great
Stock price: 0.35664335664335667
Shares outstanding: 22014377
Book value: -971647
Market cap (USD): 7851281.307692308
Debt to equity: -8.818635780278228
Current ratio: 0.83014308449376
Quick ratio: 0.83014308449376
Interest coverage ratio: 1.5985047324860873
COGS to revenue (%): 38.25482328296025
R&D to revenue (%): 11.615213510262558
SG&A to revenue (%): 44.18526664326077
Free cash flow (dilution-adjusted): 3450007
Buyback yield (%): 0.17271066299349846
Retained earnings: -15930297
Receivables turnover: 3.3528255679717796
Capitalized R&D asset: 10663872.290000001
ROCI (R&D-adjusted, %): 22.53870779365178
Rosenberg metric: 1.8828224309686448
FCF margin (%): 6.9552547195591545
Revenue growth (%): 37.95849270645303
Rule of 40 score: 44.913747426012186
Financial ratios for SBIO.V — quarterly report dated 2024-12-31
Total revenue: 18301162
Gross profit: 11286755
Operating income: 2374926
Net income: 1194528
Capital expenditures: 27343
Operating cash flow: 1118419
Depreciation & amortization: 193680
Net tangible assets: -3710643
Owner earnings: 1360865
Return on net tangible assets (%): -36.6746410258276
Capex to operating income (%): 1.1513200832362778
Buffett classification: The Great
Stock price: 0.35664335664335667
P/E ratio: 1.643176490566213
Shares outstanding: 22014377
Book value: -971647
Market cap (USD): 7851281.307692308
Debt to equity: -8.818635780278228
Current ratio: 0.83014308449376
Quick ratio: 0.83014308449376
Effective tax rate (%): 0.7148034124382443
Interest coverage ratio: 7.217413502302047
COGS to revenue (%): 38.32765919453639
R&D to revenue (%): 9.74294419119398
SG&A to revenue (%): 37.8941894509212
Free cash flow (dilution-adjusted): 1037541
Buyback yield (%): 0.1625721904460925
Retained earnings: -15930297
Receivables turnover: 1.2370369964810222
Capitalized R&D asset: 1783072
ROCI (R&D-adjusted, %): 141.65225422969087
FCF margin (%): 5.669262968110987
Rule of 40 score: 5.669262968110987
Financial ratios for SBIO.V — quarterly report dated 2025-03-31
Total revenue: 9087266
Gross profit: 5556419
Operating income: -1972538
Net income: -2293202
Capital expenditures: 7325
Operating cash flow: 971888
Depreciation & amortization: 186309
Net tangible assets: -5875489
Owner earnings: -2114218
Buffett classification: The Gruesome
Stock price: 0.4125874125874126
Shares outstanding: 22014377
Book value: -3174028
Market cap (USD): 9082854.846153846
Debt to equity: -2.5739275141870204
Current ratio: 0.6677049123094428
Quick ratio: 0.6677049123094428
Interest coverage ratio: -6.6738778120252675
COGS to revenue (%): 38.85488770769998
R&D to revenue (%): 21.34482472506032
SG&A to revenue (%): 59.45668367141448
Free cash flow (dilution-adjusted): 909284
Buyback yield (%): 0
Retained earnings: -18223499
Receivables turnover: 1.2253631280998947
Capitalized R&D asset: 3134319.24
ROCI (R&D-adjusted, %): -81.31082921843125
Rosenberg metric: -3.213743471940561
FCF margin (%): 10.006133858082288
Revenue growth (%): -50.345961638938554
Rule of 40 score: -40.33982778085627
Financial ratios for SBIO.V — quarterly report dated 2025-06-30
Total revenue: 11157319
Gross profit: 6817374
Operating income: -1602233
Net income: -1377658
Capital expenditures: 22830
Operating cash flow: -2959572
Depreciation & amortization: 227801
Net tangible assets: -7115291
Owner earnings: -1172687
Buffett classification: The Gruesome
Stock price: 0.36496350364963503
Shares outstanding: 22014377
Book value: -4435754
Market cap (USD): 8034444.160583941
Debt to equity: -2.4457185858368162
Current ratio: 0.6061198450621533
Quick ratio: 0.6061198450621533
Interest coverage ratio: -4.619542841326498
COGS to revenue (%): 38.89774057728385
R&D to revenue (%): 15.212391077103737
SG&A to revenue (%): 58.20852661826734
Free cash flow (dilution-adjusted): -3083476
Buyback yield (%): 0
Retained earnings: -19601157
Receivables turnover: 1.2556505472620691
Capitalized R&D asset: 3585281.63
ROCI (R&D-adjusted, %): -109.4942684959566
Rosenberg metric: 0.6500904023950577
FCF margin (%): -27.63635242480743
Revenue growth (%): 22.77971174168336
Rule of 40 score: -4.85664068312407
Financial ratios for SBIO.V — quarterly report dated 2025-09-30
Total revenue: 8208049
Gross profit: 4816991
Operating income: -3011210
Net income: -3347114
Capital expenditures: 42664
Operating cash flow: 1241469
Depreciation & amortization: 228568
Net tangible assets: -10276449
Owner earnings: -3161210
Buffett classification: The Gruesome
Stock price: 0.32374100719424465
Shares outstanding: 22014377
Book value: -7597756
Market cap (USD): 7126956.582733814
Debt to equity: -1.2479067503615542
Current ratio: 0.49172754101224414
Quick ratio: 0.49172754101224414
Interest coverage ratio: -9.730939385419797
COGS to revenue (%): 41.31381281958721
R&D to revenue (%): 21.66187117060339
SG&A to revenue (%): 70.92569744649428
Free cash flow (dilution-adjusted): 1118468
Buyback yield (%): 0
Retained earnings: -22849211
Receivables turnover: 1.0544755139734514
Capitalized R&D asset: 3555292.7800000003
Rosenberg metric: -1.1785711971106967
FCF margin (%): 13.626478107038592
Revenue growth (%): -26.433500736153555
Rule of 40 score: -12.807022629114963
Financial ratios for SBIO.V — quarterly report dated 2025-12-31
Total revenue: 9778763
Gross profit: 5563171
Operating income: -2563637
Net income: -2817019
Capital expenditures: 13680
Operating cash flow: -5628069
Depreciation & amortization: 224285
Net tangible assets: -12280935
Owner earnings: -2606414
Buffett classification: The Gruesome
Stock price: 0.2408759124087591
Shares outstanding: 22014377
Book value: -9627786
Market cap (USD): 5302733.145985401
Debt to equity: -1.426560789780745
Current ratio: 0.5563175586965763
Quick ratio: 0.5563175586965763
Interest coverage ratio: -5.773541096137215
COGS to revenue (%): 43.10966530224733
R&D to revenue (%): 19.91273333856235
SG&A to revenue (%): 60.90038177630442
Free cash flow (dilution-adjusted): -5695669
Buyback yield (%): 0
Retained earnings: -25666230
Receivables turnover: 0.7260986248343332
Capitalized R&D asset: 3698597.74
Rosenberg metric: 0.4196697781854729
FCF margin (%): -58.24529135229067
Revenue growth (%): 19.136264902902017
Rule of 40 score: -39.10902644938865
Financial ratios for SBIO.V — annual report dated 2025-12-31
Total revenue: 38231397
Gross profit: 22753955
Operating income: -9149618
Net income: -9834993
Capital expenditures: 86499
Operating cash flow: -6374284
Depreciation & amortization: 866963
Net tangible assets: -12280935
Owner earnings: -9054529
Buffett classification: The Gruesome
Stock price: 0.2408759124087591
Shares outstanding: 22014377
Book value: -9627786
Market cap (USD): 5302733.145985401
Debt to equity: -1.426560789780745
Current ratio: 0.5563175586965763
Quick ratio: 0.5563175586965763
Interest coverage ratio: -6.554740457260592
COGS to revenue (%): 40.48358996664443
R&D to revenue (%): 19.256926447129306
SG&A to revenue (%): 61.9240201973263
Free cash flow (dilution-adjusted): -6751393
Buyback yield (%): 0
Retained earnings: -25666230
Receivables turnover: 2.838780813810034
Capitalized R&D asset: 12773002.459999999
ROCI (R&D-adjusted, %): -149.24660807982627
Rosenberg metric: -1.366564256655537
FCF margin (%): -17.65928930088534
Revenue growth (%): -22.925053653633253
Rule of 40 score: -40.58434295451859
Financial ratios for SHOP.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 137.14173228346456
Shares outstanding: 1219581025
Market cap (USD): 167255454428.5433
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOP.TO — annual report dated 2022-12-31
Total revenue: 4117647058.8235292
Gross profit: 2024999999.9999998
Operating income: -505147058.82352936
Net income: -2544117647.058823
Capital expenditures: 36764705.88235294
Operating cash flow: -100000000
Depreciation & amortization: 68382352.94117646
Net tangible assets: 4421323529.411764
Owner earnings: -2512499999.9999995
Return on net tangible assets (%): -56.826875103941454
Buffett classification: The Gruesome
Stock price: 34.56617647058823
Shares outstanding: 1219581025
Book value: 6058088235.294117
P/B ratio: 6.95867265265809
Market cap (USD): 42156252930.33088
Debt to equity: 0.1694380385969171
Current ratio: 7.067757009345795
Quick ratio: 7.067757009345795
Interest coverage ratio: -597.3913043478261
COGS to revenue (%): 50.82142857142857
R&D to revenue (%): 26.839285714285708
SG&A to revenue (%): 34.60714285714286
Free cash flow (dilution-adjusted): -540441176.4705882
Buyback yield (%): 0
Retained earnings: -383823529.4117647
Receivables turnover: 6.3276836158192085
Capitalized R&D asset: 1105147058.8235292
ROCI (R&D-adjusted, %): 2.762188705717292
FCF margin (%): -13.125
Rule of 40 score: -13.125
Financial ratios for SHOP.TO — annual report dated 2023-12-31
Total revenue: 5348484848.484848
Gross profit: 2662878787.8787875
Operating income: 56060606.060606055
Net income: 100000000
Capital expenditures: 29545454.545454543
Operating cash flow: 715151515.1515151
Depreciation & amortization: 53030303.03030303
Net tangible assets: 6522727272.727272
Owner earnings: 123484848.48484848
Return on net tangible assets (%): 1.8931475029036007
Capex to operating income (%): 52.70270270270271
Buffett classification: The Good
Stock price: 78.15151515151514
P/E ratio: 953.1210495378787
Shares outstanding: 1219581025
Book value: 6868181818.181818
P/B ratio: 13.877341555151112
Market cap (USD): 95312104953.78787
Debt to equity: 0.12684756232075886
Current ratio: 6.987750556792874
Quick ratio: 6.966592427616928
Effective tax rate (%): 28.648648648648646
COGS to revenue (%): 50.212464589235125
R&D to revenue (%): 24.504249291784703
SG&A to revenue (%): 24.235127478753544
Free cash flow (dilution-adjusted): 219696969.69696975
Buyback yield (%): 0
Retained earnings: -295454545.45454544
Inventory turnover: 186.57894736842107
Receivables turnover: 6.112554112554112
Capitalized R&D asset: 2051054590.0178251
ROCI (R&D-adjusted, %): 5.653390775355638
Rosenberg metric: 0.5771890562309724
FCF margin (%): 4.107648725212465
Revenue growth (%): 29.891774891774887
Rule of 40 score: 33.99942361698735
Financial ratios for SHOP.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 80.25925925925925
Shares outstanding: 1219581025
Market cap (USD): 97882669673.14813
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOP.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 106.986013986014
Shares outstanding: 1219581025
Market cap (USD): 130478112597.7273
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOP.TO — annual report dated 2024-12-31
Total revenue: 6209790209.79021
Gross profit: 3127272727.2727275
Operating income: 910489510.4895105
Net income: 1411888111.888112
Capital expenditures: 13286713.286713287
Operating cash flow: 1130069930.06993
Depreciation & amortization: 25174825.174825177
Net tangible assets: 7751048951.048951
Owner earnings: 1423776223.776224
Return on net tangible assets (%): 18.36881992060628
Capex to operating income (%): 1.4592933947772657
Buffett classification: The Great
Stock price: 106.986013986014
P/E ratio: 92.41391828368003
Shares outstanding: 1219581025
Book value: 8082517482.517483
P/B ratio: 16.14325151537896
Market cap (USD): 130478112597.7273
Debt to equity: 0.09742169925592663
Current ratio: 3.708588957055215
Quick ratio: 3.6952965235173827
Effective tax rate (%): 9.380610412926393
COGS to revenue (%): 49.63963963963964
R&D to revenue (%): 15.394144144144144
SG&A to revenue (%): 20.304054054054056
Free cash flow (dilution-adjusted): 816083916.083916
Buyback yield (%): 0
Retained earnings: 1139160839.1608393
Inventory turnover: 169.53846153846155
Receivables turnover: 5.365558912386707
Capitalized R&D asset: 2198748645.961881
ROCI (R&D-adjusted, %): 7.026267546549233
Rosenberg metric: 0.3543352601156074
FCF margin (%): 13.141891891891891
Revenue growth (%): 16.103726302026594
Rule of 40 score: 29.245618193918485
Financial ratios for SHOP.TO — quarterly report dated 2025-03-31
Total revenue: 1650349650.3496504
Gross profit: 817482517.4825175
Operating income: 194405594.4055944
Net income: -476923076.9230769
Capital expenditures: 2797202.797202797
Operating cash flow: 256643356.64335665
Depreciation & amortization: 5594405.594405594
Net tangible assets: 7357342657.342658
Owner earnings: -474125874.12587416
Return on net tangible assets (%): -6.4442543484459645
Capex to operating income (%): 1.4388489208633093
Buffett classification: The Great
Stock price: 95.73426573426575
Shares outstanding: 1219581025
Book value: 7727972027.972029
P/B ratio: 15.108193133879288
Market cap (USD): 116755693931.81819
Debt to equity: 0.10297710614424034
Current ratio: 3.7058237929318074
Quick ratio: 3.7058237929318074
COGS to revenue (%): 50.46610169491525
R&D to revenue (%): 15.974576271186441
SG&A to revenue (%): 21.779661016949152
Free cash flow (dilution-adjusted): 174125874.12587413
Buyback yield (%): 0
Retained earnings: 662237762.2377622
Receivables turnover: 1.3972764949674363
Capitalized R&D asset: 263636363.63636366
ROCI (R&D-adjusted, %): 4.498073872648992
FCF margin (%): 10.55084745762712
Rule of 40 score: 10.55084745762712
Financial ratios for SHOP.TO — quarterly report dated 2025-06-30
Total revenue: 1956204379.5620437
Gross profit: 950364963.5036496
Operating income: 270802919.70802915
Net income: 661313868.6131387
Capital expenditures: 4379562.04379562
Operating cash flow: 312408759.1240876
Depreciation & amortization: 5839416.05839416
Net tangible assets: 8464963503.649634
Owner earnings: 662773722.6277373
Return on net tangible assets (%): 7.829611106320601
Capex to operating income (%): 1.6172506738544474
Buffett classification: The Great
Stock price: 114.64233576642334
P/E ratio: 758.2570478759135
Shares outstanding: 1219581025
Book value: 8849635036.49635
P/B ratio: 15.799026376319697
Market cap (USD): 139815617362.40875
Debt to equity: 0.09394589244473771
Current ratio: 3.8503368623676613
Quick ratio: 3.8503368623676613
Effective tax rate (%): 16.033364226135312
COGS to revenue (%): 51.417910447761194
R&D to revenue (%): 14.701492537313431
SG&A to revenue (%): 20.03731343283582
Free cash flow (dilution-adjusted): 225547445.25547442
Buyback yield (%): 0
Retained earnings: 1352554744.5255473
Receivables turnover: 1.376476630713919
Capitalized R&D asset: 464227604.51227605
ROCI (R&D-adjusted, %): 3.9124403337257543
Rosenberg metric: 0.5040368642180872
FCF margin (%): 11.529850746268657
Revenue growth (%): 18.53272299888654
Rule of 40 score: 30.0625737451552
Financial ratios for SHOP.TO — quarterly report dated 2025-09-30
Total revenue: 2046043165.467626
Gross profit: 1000719424.4604317
Operating income: 353237410.07194245
Net income: 189928057.55395684
Capital expenditures: 4316546.762589929
Operating cash flow: 369064748.2014389
Depreciation & amortization: 5755395.683453238
Net tangible assets: 8623741007.194244
Owner earnings: 191366906.47482014
Return on net tangible assets (%): 2.219070659881538
Capex to operating income (%): 1.2219959266802445
Buffett classification: The Great
Stock price: 148.74820143884892
P/E ratio: 484.6415945765966
Shares outstanding: 1219581025
Book value: 9000719424.460432
P/B ratio: 20.155109322116537
Market cap (USD): 181410483977.69785
Debt to equity: 0.08912157301574614
Current ratio: 3.9335743334839584
Quick ratio: 3.9335743334839584
Effective tax rate (%): 14.285714285714288
COGS to revenue (%): 51.090014064697606
R&D to revenue (%): 13.185654008438819
SG&A to revenue (%): 18.459915611814345
Free cash flow (dilution-adjusted): 287769784.1726619
Buyback yield (%): 0
Retained earnings: 1523021582.733813
Receivables turnover: 1.3358384217942696
Capitalized R&D asset: 549470304.0487318
ROCI (R&D-adjusted, %): 3.573262099968894
Rosenberg metric: 0.17509038454515607
FCF margin (%): 14.064697609001406
Revenue growth (%): 4.592505100397311
Rule of 40 score: 18.657202709398717
Financial ratios for SHOP.TO — quarterly report dated 2025-12-31
Total revenue: 2680291970.8029194
Gross profit: 1235766423.357664
Operating income: 543795620.4379562
Net income: 542335766.4233576
Capital expenditures: 7299270.0729927
Operating cash flow: 529197080.2919708
Depreciation & amortization: 5109489.051094891
Net tangible assets: 9454014598.540146
Owner earnings: 540145985.4014598
Return on net tangible assets (%): 5.713403335392217
Capex to operating income (%): 1.3422818791946307
Buffett classification: The Great
Stock price: 161.31386861313868
P/E ratio: 214.6231850768488
Shares outstanding: 1219581025
Book value: 9834306569.343065
P/B ratio: 20.005003082090106
Market cap (USD): 196735333229.927
Debt to equity: 0.01395383359311215
Current ratio: 5.959770114942528
Quick ratio: 5.944683908045977
Effective tax rate (%): 16.70403587443946
COGS to revenue (%): 53.894335511982575
R&D to revenue (%): 10.62091503267974
SG&A to revenue (%): 15.19607843137255
Free cash flow (dilution-adjusted): 437956204.379562
Buyback yield (%): 0
Retained earnings: 2087591240.8759122
Inventory turnover: 94.23809523809523
Receivables turnover: 1.549367088607595
Capitalized R&D asset: 560332038.0192196
ROCI (R&D-adjusted, %): 5.152646824646076
Rosenberg metric: 0.8712408759124081
FCF margin (%): 16.33986928104575
Revenue growth (%): 30.99879885429176
Rule of 40 score: 47.338668135337514
Financial ratios for SHOP.TO — annual report dated 2025-12-31
Total revenue: 8435036496.350365
Gross profit: 4054744525.547445
Operating income: 1375912408.759124
Net income: 898540145.9854014
Capital expenditures: 18978102.18978102
Operating cash flow: 1483941605.839416
Depreciation & amortization: 22627737.22627737
Net tangible assets: 9454014598.540146
Owner earnings: 902189781.0218977
Return on net tangible assets (%): 9.542927733168622
Capex to operating income (%): 1.3793103448275863
Buffett classification: The Great
Stock price: 161.31386861313868
P/E ratio: 218.94996468318442
Shares outstanding: 1219581025
Book value: 9834306569.343065
P/B ratio: 20.005003082090106
Market cap (USD): 196735333229.927
Debt to equity: 0.01395383359311215
Current ratio: 5.959770114942528
Quick ratio: 5.944683908045977
Effective tax rate (%): 18.42279655400928
COGS to revenue (%): 51.92973347178954
R&D to revenue (%): 13.291796469366563
SG&A to revenue (%): 18.466597438560058
Free cash flow (dilution-adjusted): 1137226277.3722625
Buyback yield (%): 0
Retained earnings: 2087591240.8759122
Inventory turnover: 285.76190476190476
Receivables turnover: 4.875949367088608
Capitalized R&D asset: 2194150400.694196
ROCI (R&D-adjusted, %): 11.15243509685052
Rosenberg metric: 0.9702155607409259
FCF margin (%): 13.482173762547593
Revenue growth (%): 35.83448411915565
Rule of 40 score: 49.316657881703236
Financial ratios for SIDU — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 34767
Buffett classification: The Gruesome
Stock price: 1052
Shares outstanding: 97249892
Market cap (USD): 102306886384
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SIDU — annual report dated 2022-12-31
Total revenue: 7293408
Gross profit: 1438133
Operating income: -12044299
Net income: -12839968
Capital expenditures: 2099858
Operating cash flow: -12093908
Depreciation & amortization: 319936
Net tangible assets: 3875213
Owner earnings: -14619890
Return on net tangible assets (%): -377.26674636981244
Buffett classification: The Gruesome
Stock price: 109
Shares outstanding: 97249892
Book value: 3875213
P/B ratio: 2735.3949906753514
Market cap (USD): 10600238228
Debt to equity: 0.6215444157521148
Current ratio: 1.1715375184854597
Quick ratio: 1.0797884653247056
Interest coverage ratio: -15.414216715128184
COGS to revenue (%): 80.281742088198
SG&A to revenue (%): 184.85777842128124
Free cash flow (dilution-adjusted): -15402766
Buyback yield (%): 0
Retained earnings: -28255846
Inventory turnover: 10.03583077521652
Receivables turnover: 6.6641521019275896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -305.80750702738055
FCF margin (%): -211.1874997257798
Rule of 40 score: -211.1874997257798
Financial ratios for SIDU — annual report dated 2023-12-31
Total revenue: 5962785
Gross profit: 1641303
Operating income: -12525314
Net income: -14328348
Capital expenditures: 7208200
Operating cash flow: -11749442
Depreciation & amortization: 217107
Net tangible assets: 6733621
Owner earnings: -21319441
Return on net tangible assets (%): -316.611834850818
Buffett classification: The Gruesome
Stock price: 8.81
Shares outstanding: 97249892
Book value: 7131756
P/B ratio: 120.13472537759284
Market cap (USD): 856771548.5200001
Debt to equity: 0.675609765673419
Current ratio: 0.7530928798538974
Quick ratio: 0.6828238738604555
Interest coverage ratio: -16.75806641513473
COGS to revenue (%): 72.47422135797282
SG&A to revenue (%): 237.5838974573123
Free cash flow (dilution-adjusted): -19979528
Buyback yield (%): 0
Retained earnings: -42786793
Inventory turnover: 5.032926411705926
Receivables turnover: 3.4624918994627514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -175.62734900072297
FCF margin (%): -335.07040753607583
Revenue growth (%): -18.244187079620392
Rule of 40 score: -353.31459461569625
Financial ratios for SIDU — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 97249892
Market cap (USD): 272299697.59999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SIDU — annual report dated 2024-12-31
Total revenue: 4672646
Gross profit: -1469011
Operating income: -15718881
Net income: -17524056
Capital expenditures: 7474836
Operating cash flow: -15825052
Depreciation & amortization: 2171873
Net tangible assets: 23137930
Owner earnings: -22827019
Return on net tangible assets (%): -98.65627132591376
Buffett classification: The Gruesome
Stock price: 4.9
Shares outstanding: 97249892
Book value: 23536065
P/B ratio: 20.246565039652975
Market cap (USD): 476524470.8
Debt to equity: 0.4306356648828086
Current ratio: 1.566033207919602
Quick ratio: 1.5480370811024904
Interest coverage ratio: -12.03357468543589
COGS to revenue (%): 131.43852540937192
SG&A to revenue (%): 304.96361162390644
Free cash flow (dilution-adjusted): -23589063
Buyback yield (%): 0
Retained earnings: -60353224
Inventory turnover: 24.017492061505735
Receivables turnover: 1.4979708699051748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -66.78635957200152
FCF margin (%): -504.83308600737143
Revenue growth (%): -21.636517164378727
Rule of 40 score: -526.4696031717501
Financial ratios for SIDU — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.9
Shares outstanding: 97249892
Market cap (USD): 476524470.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SIDU — quarterly report dated 2025-03-31
Total revenue: 238494
Gross profit: -1628478
Operating income: -6072920
Net income: -6414627
Capital expenditures: 2978308
Operating cash flow: -3207213
Depreciation & amortization: 934673
Net tangible assets: 19356794
Owner earnings: -8458262
Return on net tangible assets (%): -43.696605956544246
Buffett classification: The Gruesome
Stock price: 1.48
Shares outstanding: 97249892
Book value: 19754929
P/B ratio: 7.285768537057258
Market cap (USD): 143929840.16
Debt to equity: 0.5011726440525299
Current ratio: 1.1607659696840387
Quick ratio: 1.1507182766644908
Interest coverage ratio: -80.53522882491015
COGS to revenue (%): 782.8171777906363
SG&A to revenue (%): 1863.5445755448775
Free cash flow (dilution-adjusted): -6437765
Buyback yield (%): 0
Retained earnings: -66767851
Inventory turnover: 13.058305122681364
Receivables turnover: 0.09559690041799143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.74128993326172
FCF margin (%): -2699.340444623345
Rule of 40 score: -2699.340444623345
Financial ratios for SIDU — quarterly report dated 2025-06-30
Total revenue: 1261023
Gross profit: -1027142
Operating income: -5290411
Net income: -5625070
Capital expenditures: 1375822
Operating cash flow: -4638146
Depreciation & amortization: 1132296
Net tangible assets: 13916172
Owner earnings: -5868596
Return on net tangible assets (%): -42.171051062030564
Buffett classification: The Gruesome
Stock price: 1.73
Shares outstanding: 97249892
Book value: 14314307
P/B ratio: 11.753437533511054
Market cap (USD): 168242313.16
Debt to equity: 0.6133373414444723
Current ratio: 0.7559000232619223
Quick ratio: 0.7308608440410573
Interest coverage ratio: -2077.9304791830323
COGS to revenue (%): 181.45307421038314
SG&A to revenue (%): 338.0801936205763
Free cash flow (dilution-adjusted): -6198416
Buyback yield (%): 0
Retained earnings: -72392921
Inventory turnover: 6.183110085471009
Receivables turnover: 0.4187108192105403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.530186391383964
FCF margin (%): -491.53869517050845
Revenue growth (%): 428.7441193489144
Rule of 40 score: -62.79457582159404
Financial ratios for SIDU — quarterly report dated 2025-09-30
Total revenue: 1298058
Gross profit: -1298965
Operating income: -5631406
Net income: -6033599
Capital expenditures: 1435675
Operating cash flow: -6219752
Depreciation & amortization: 1157840
Net tangible assets: 23583026
Owner earnings: -6311434
Return on net tangible assets (%): -26.762613076031887
Buffett classification: The Gruesome
Stock price: 1.04
Shares outstanding: 97249892
Book value: 23981161
P/B ratio: 4.21747252687224
Market cap (USD): 101139887.68
Debt to equity: 0.41605129126150314
Current ratio: 1.3755468059658282
Quick ratio: 1.363290047076993
Interest coverage ratio: -5175.924632352941
COGS to revenue (%): 200.06987361119454
SG&A to revenue (%): 333.7632833047522
Free cash flow (dilution-adjusted): -7844042
Buyback yield (%): 0
Retained earnings: -78426520
Inventory turnover: 13.791211300515108
Receivables turnover: 0.3861145376336282
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.99764702557643
FCF margin (%): -604.2905632876189
Revenue growth (%): 2.9369012301916775
Rule of 40 score: -601.3536620574272
Financial ratios for SIDU — annual report dated 2025-12-31
Total revenue: 3383878
Gross profit: -5692567
Operating income: -28008136
Net income: -29474304
Capital expenditures: 8174345
Operating cash flow: -18153485
Depreciation & amortization: 4371262
Net tangible assets: 50237142
Owner earnings: -33277387
Return on net tangible assets (%): -66.24060540705122
Buffett classification: The Gruesome
Stock price: 3.14
Shares outstanding: 97249892
Book value: 50635277
P/B ratio: 6.030670294940817
Market cap (USD): 305364660.88
Debt to equity: 0.17672714617518534
Current ratio: 3.3745736478078743
Quick ratio: 3.3745736478078743
Interest coverage ratio: -310.7043840965566
COGS to revenue (%): 268.2261299018463
SG&A to revenue (%): 659.4673034902559
Free cash flow (dilution-adjusted): -27181012
Buyback yield (%): 0
Retained earnings: -89827528
Receivables turnover: 1.3358031845685485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.842669582822566
FCF margin (%): -803.2503535883977
Revenue growth (%): -27.581117850571175
Rule of 40 score: -830.831471438969
Financial ratios for SIDU — quarterly report dated 2025-12-31
Total revenue: 586303
Gross profit: -1737982
Operating income: -11013399
Net income: -11401008
Capital expenditures: 2384540
Operating cash flow: -4088374
Depreciation & amortization: 1146453
Net tangible assets: 50237142
Owner earnings: -12639095
Return on net tangible assets (%): -25.158865526227586
Buffett classification: The Gruesome
Stock price: 3.14
Shares outstanding: 97249892
Book value: 50635277
P/B ratio: 6.030670294940817
Market cap (USD): 305364660.88
Debt to equity: 0.17672714617518534
Current ratio: 3.3745736478078743
Quick ratio: 3.3745736478078743
COGS to revenue (%): 396.4306851576744
SG&A to revenue (%): 1582.0176598107123
Free cash flow (dilution-adjusted): -6700789
Buyback yield (%): 0
Retained earnings: -89827528
Receivables turnover: 0.23144611434634868
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.565312391399
FCF margin (%): -1142.8884041186896
Revenue growth (%): -54.83229562931703
Rule of 40 score: -1197.7206997480066
Financial ratios for TACT — annual report dated 2021-12-31
Capital expenditures: 8000
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 10276279
Market cap (USD): 112011441.10000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TACT — annual report dated 2022-12-31
Total revenue: 58139000
Gross profit: 24412000
Operating income: -7677000
Net income: -5936000
Capital expenditures: 0
Operating cash flow: -12220000
Depreciation & amortization: 1332000
Net tangible assets: 30999000
Owner earnings: -4604000
Return on net tangible assets (%): -14.852092002967836
Buffett classification: The Gruesome
Stock price: 6.32
Shares outstanding: 10276279
Book value: 33862000
P/B ratio: 1.917963595771071
Market cap (USD): 64946083.28
Debt to equity: 0.14198806922213691
Current ratio: 2.268303403239985
Quick ratio: 1.5130604043702123
Interest coverage ratio: -36.90865384615385
COGS to revenue (%): 58.01097370095805
R&D to revenue (%): 14.740535612927639
SG&A to revenue (%): 40.45305216807994
Free cash flow (dilution-adjusted): -14674000
Buyback yield (%): 0
Retained earnings: 9630000
Inventory turnover: 2.80404057199867
Receivables turnover: 3.7686523627406494
Capitalized R&D asset: 8570000
ROCI (R&D-adjusted, %): -4.415115268159607
FCF margin (%): -25.23951220351227
Rule of 40 score: -25.23951220351227
Financial ratios for TACT — annual report dated 2023-12-31
Total revenue: 72631000
Gross profit: 38400000
Operating income: 5706000
Net income: 4748000
Capital expenditures: 901000
Operating cash flow: 5507000
Depreciation & amortization: 1489000
Net tangible assets: 36705000
Owner earnings: 5336000
Return on net tangible assets (%): 14.537528947009944
Capex to operating income (%): 15.790396074307747
Buffett classification: The Great
Stock price: 6.98
P/E ratio: 15.107082438921651
Shares outstanding: 10276279
Book value: 39414000
P/B ratio: 1.8198718074795759
Market cap (USD): 71728427.42
Debt to equity: 0.09892424011772466
Current ratio: 3.0066735112936347
Quick ratio: 1.7043121149897331
Effective tax rate (%): 19.56632220904625
Interest coverage ratio: 18.406451612903226
COGS to revenue (%): 47.13001335517892
R&D to revenue (%): 12.999958695322933
SG&A to revenue (%): 32.013878371494265
Free cash flow (dilution-adjusted): 3746000
Buyback yield (%): 0
Retained earnings: 14378000
Inventory turnover: 1.9275297032490568
Receivables turnover: 7.393220684039088
Capitalized R&D asset: 15183900
ROCI (R&D-adjusted, %): 16.40300004125864
Rosenberg metric: 1.6322053675612602
FCF margin (%): 5.157577343007807
Revenue growth (%): 24.92646932351778
Rule of 40 score: 30.084046666525587
Financial ratios for TACT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.86
Shares outstanding: 10276279
Market cap (USD): 49942715.940000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TACT — annual report dated 2024-12-31
Total revenue: 43384000
Gross profit: 21482000
Operating income: -3626000
Net income: -9863000
Capital expenditures: 322000
Operating cash flow: 1861000
Depreciation & amortization: 1037000
Net tangible assets: 28012000
Owner earnings: -9148000
Return on net tangible assets (%): -32.65743252891618
Buffett classification: The Gruesome
Stock price: 4.09
Shares outstanding: 10276279
Book value: 30633000
P/B ratio: 1.3720491336140763
Market cap (USD): 42029981.11
Debt to equity: 0.13665001795449352
Current ratio: 2.9774914622787954
Quick ratio: 1.7231449860291834
Interest coverage ratio: -11.26086956521739
COGS to revenue (%): 50.484049419140696
R&D to revenue (%): 16.081965701641156
SG&A to revenue (%): 41.79190484971418
Free cash flow (dilution-adjusted): 382000
Buyback yield (%): 0
Retained earnings: 4515000
Inventory turnover: 1.3552379184456407
Receivables turnover: 6.66728138927309
Capitalized R&D asset: 16131240
ROCI (R&D-adjusted, %): -10.529898680040258
Rosenberg metric: -1.791781402245287
FCF margin (%): 0.8805089433892679
Revenue growth (%): -40.26792967190318
Rule of 40 score: -39.387420728513916
Financial ratios for TACT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.09
Shares outstanding: 10276279
Market cap (USD): 42029981.11
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TACT — quarterly report dated 2025-03-31
Total revenue: 13053000
Gross profit: 6359000
Operating income: -15000
Net income: 19000
Capital expenditures: 10000
Operating cash flow: -161000
Depreciation & amortization: 173000
Net tangible assets: 28320000
Owner earnings: 182000
Return on net tangible assets (%): 0.6426553672316384
Buffett classification: The Gruesome
Stock price: 3.68
P/E ratio: 497.5882463157895
Shares outstanding: 10276279
Book value: 30941000
P/B ratio: 1.2222199256649753
Market cap (USD): 37816706.72
Debt to equity: 0.12759768591836076
Current ratio: 3.051913425345044
Quick ratio: 1.9215025094102887
Effective tax rate (%): 72.85714285714285
COGS to revenue (%): 51.28322990883321
R&D to revenue (%): 12.525856125028728
SG&A to revenue (%): 36.30583007737685
Free cash flow (dilution-adjusted): -494000
Buyback yield (%): 0
Retained earnings: 4534000
Inventory turnover: 0.46437738466874784
Receivables turnover: 1.440410505407195
Capitalized R&D asset: 1635000
ROCI (R&D-adjusted, %): 3.252942778467032
FCF margin (%): -3.7845705967976713
Rule of 40 score: -3.7845705967976713
Financial ratios for TACT — quarterly report dated 2025-06-30
Total revenue: 13798000
Gross profit: 6652000
Operating income: -258000
Net income: -143000
Capital expenditures: 19000
Operating cash flow: 3595000
Depreciation & amortization: 171000
Net tangible assets: 28664000
Owner earnings: 9000
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 10276279
Book value: 31285000
P/B ratio: 1.202211319801822
Market cap (USD): 37611181.14
Debt to equity: 0.1183634329550903
Current ratio: 3.0801707411719055
Quick ratio: 2.0737291424136592
COGS to revenue (%): 51.79011450934918
R&D to revenue (%): 12.50181185679084
SG&A to revenue (%): 37.577909842006086
Free cash flow (dilution-adjusted): 3126000
Buyback yield (%): 0
Retained earnings: 4391000
Inventory turnover: 0.5510487353485503
Receivables turnover: 1.767841127482383
Capitalized R&D asset: 2820450
ROCI (R&D-adjusted, %): 1.0062506434059408
Rosenberg metric: 0.17920489296636086
FCF margin (%): 22.655457312654008
Revenue growth (%): 5.707500191526852
Rule of 40 score: 28.36295750418086
Financial ratios for TACT — quarterly report dated 2025-09-30
Total revenue: 13176000
Gross profit: 6556000
Operating income: 14000
Net income: 15000
Capital expenditures: 1412000
Operating cash flow: 3630000
Depreciation & amortization: 163000
Net tangible assets: 27805000
Owner earnings: -1234000
Return on net tangible assets (%): -4.438050710303902
Capex to operating income (%): 10085.714285714286
Buffett classification: The Gruesome
Stock price: 5.42
P/E ratio: 928.2905363333334
Shares outstanding: 10276279
Book value: 31778000
P/B ratio: 1.7527041406004151
Market cap (USD): 55697432.18
Debt to equity: 0.1081565863175782
Current ratio: 3.052861375331358
Quick ratio: 2.1379229689692814
Effective tax rate (%): 62.5
COGS to revenue (%): 50.242865816636304
R&D to revenue (%): 12.568306010928962
SG&A to revenue (%): 37.08257437765635
Free cash flow (dilution-adjusted): 1691000
Buyback yield (%): 0
Retained earnings: 4406000
Inventory turnover: 0.5641244141457179
Receivables turnover: 2.256550779243021
Capitalized R&D asset: 3351300
ROCI (R&D-adjusted, %): -0.005632485925825792
Rosenberg metric: -0.05565217391304348
FCF margin (%): 12.833940497874924
Revenue growth (%): -4.507899695608059
Rule of 40 score: 8.326040802266863
Financial ratios for TACT — quarterly report dated 2025-12-31
Total revenue: 11453000
Gross profit: 5448000
Operating income: -1156000
Net income: -1131000
Capital expenditures: 171000
Operating cash flow: 609000
Depreciation & amortization: 165000
Net tangible assets: 26992000
Owner earnings: -1137000
Return on net tangible assets (%): -4.21235921754594
Buffett classification: The Gruesome
Stock price: 4
Shares outstanding: 10276279
Book value: 31116000
P/B ratio: 1.321028281270086
Market cap (USD): 41105116
Debt to equity: 0.11444273042807558
Current ratio: 2.9742489270386265
Quick ratio: 2.1420907418761495
COGS to revenue (%): 52.431677289793065
R&D to revenue (%): 14.712302453505632
SG&A to revenue (%): 42.94944556011525
Free cash flow (dilution-adjusted): -64000
Buyback yield (%): 0
Retained earnings: 3275000
Inventory turnover: 0.5530484435439308
Receivables turnover: 1.799654305468259
Capitalized R&D asset: 3363770
ROCI (R&D-adjusted, %): -3.3053278293306945
Rosenberg metric: -0.6690821256038647
FCF margin (%): -0.5588055531301842
Revenue growth (%): -13.076806314511233
Rule of 40 score: -13.635611867641417
Financial ratios for TACT — annual report dated 2025-12-31
Total revenue: 51480000
Gross profit: 25015000
Operating income: -1415000
Net income: -1240000
Capital expenditures: 1612000
Operating cash flow: 7673000
Depreciation & amortization: 672000
Net tangible assets: 26992000
Owner earnings: -2180000
Return on net tangible assets (%): -8.076467101363367
Buffett classification: The Gruesome
Stock price: 4
Shares outstanding: 10276279
Book value: 31116000
P/B ratio: 1.321028281270086
Market cap (USD): 41105116
Debt to equity: 0.11444273042807558
Current ratio: 2.9742489270386265
Quick ratio: 2.1420907418761495
Interest coverage ratio: -4.174041297935103
COGS to revenue (%): 51.40831390831391
R&D to revenue (%): 13.016705516705517
SG&A to revenue (%): 38.32362082362082
Free cash flow (dilution-adjusted): 4259000
Buyback yield (%): 0
Retained earnings: 3275000
Inventory turnover: 2.4373733652606373
Receivables turnover: 8.089252042740414
Capitalized R&D asset: 14491450
ROCI (R&D-adjusted, %): -5.238126666443063
Rosenberg metric: 0.5063780994696861
FCF margin (%): 8.273115773115773
Revenue growth (%): 18.66125760649087
Rule of 40 score: 26.934373379606644
Financial ratios for TRANSWORLD.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.84135566398523
Shares outstanding: 21957533
Market cap (USD): 106304226.7566926
Buyback yield (%): 0
Retained earnings: 55215613.87313728
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRANSWORLD.NS — annual report dated 2023-03-31
Total revenue: 58767356.881851405
Gross profit: 25925700.36540804
Operating income: 24554202.192448236
Net income: 23982947.624847747
Capital expenditures: 53549330.08526188
Operating cash flow: 28169305.724725947
Depreciation & amortization: 5785627.283800244
Net tangible assets: 99728380.02436054
Owner earnings: -23780755.17661389
Return on net tangible assets (%): -23.845524384137185
Capex to operating income (%): 218.08621459397787
Buffett classification: The Gruesome
Stock price: 2.8866017052375157
P/E ratio: 2.6428216077552062
Shares outstanding: 21957533
Book value: 99728380.02436054
P/B ratio: 0.6355528103948607
Market cap (USD): 63382652.20060902
Debt to equity: 0.6088400894023963
Current ratio: 1.1796102992345163
Quick ratio: 1.0491997216423103
Effective tax rate (%): 1.2438559534557125
Interest coverage ratio: 12.497830130192188
COGS to revenue (%): 55.884181727740014
SG&A to revenue (%): 0.5015751948267286
Free cash flow (dilution-adjusted): -31937880.633373935
Buyback yield (%): 0
Retained earnings: 69437271.61997564
Inventory turnover: 14.38794023479189
Receivables turnover: 77.56913183279742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.609951634299275
FCF margin (%): -54.34629414690764
Rule of 40 score: -54.34629414690764
Financial ratios for TRANSWORLD.NS — annual report dated 2024-03-31
Total revenue: 33733061.518167645
Gross profit: -5202062.597433745
Operating income: -6639884.878282768
Net income: -6117040.412519487
Capital expenditures: 5452692.169324859
Operating cash flow: 2273653.9153375705
Depreciation & amortization: 9551504.976615902
Net tangible assets: 91921093.6563137
Owner earnings: -2018227.6052284436
Return on net tangible assets (%): -2.1956087824351287
Buffett classification: The Gruesome
Stock price: 3.0942898272552783
Shares outstanding: 21957533
Book value: 91921093.6563137
P/B ratio: 0.7391445019959827
Market cap (USD): 67942970.99352208
Debt to equity: 0.5286681538883018
Current ratio: 1.3153635533921508
Quick ratio: 1.2525098874353513
Interest coverage ratio: -1.5933812949640287
COGS to revenue (%): 115.42125844294348
SG&A to revenue (%): 1.1198009242801281
Free cash flow (dilution-adjusted): -2939201.343086701
Buyback yield (%): 0
Retained earnings: 61814366.23096295
Inventory turnover: 31.43078412391094
Receivables turnover: 35.652724968314324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.1140194511919175
FCF margin (%): -8.713117667970138
Revenue growth (%): -42.598981291627354
Rule of 40 score: -51.31209895959749
Financial ratios for TRANSWORLD.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 94395604.3956044
Buffett classification: The Gruesome
Stock price: 3.942188246536073
Shares outstanding: 21957533
Book value: 94395604.39560439
P/B ratio: 0.916999568674394
Market cap (USD): 86560728.51552796
Debt to equity: 0.482917446980817
Current ratio: 1.4561277705345503
Quick ratio: 1.396936114732725
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRANSWORLD.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.804056416831798
Shares outstanding: 21957533
Market cap (USD): 105485227.30644596
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0